CMC Expertise FDA-inspected contract research and manufacturing organization with specialized focus on analytical chemistry for drug substance, drug products, and excipients, offering services from method development to cGMP manufacturing and sterile fill, presenting a full analytical and manufacturing partner for pharma developers seeking external CMC support.

Sterile Fill Capacity In-house cGMP sterile fill manufacturing facility (ISO 5 clean rooms) established since 2016 in Lee’s Summit, enabling parenteral fill/finish capabilities and potential to attract clients requiring sterile manufacturing and fill-finish services.

Recent Asset investments Facility acquisition and refurbishment completed in 2023 to align with new processes and equipment, creating opportunities to market upgraded sterile and analytical capabilities as enhanced capacity for niche or accelerated development programs.

Growth Focus Revenue in the mid tens of millions with a lean team (11-50 employees) and a strategic emphasis on quality, timing, and price, suggesting scalable partnerships for mid-sized pharma companies needing reliable, cost-conscious CMC and analytical services with a faster turnaround.

Industry Footprint Active participation in industry events such as DCAT Week and strong North America focus, presenting openings for direct outreach to biotech and pharma companies seeking regional CMC/analytical support and potential co-development or supplier relationships.